Clinical trials are integral to the development of novel therapies for cancer patients. Each trial must be carefully designed to include tests to determine the appropriate dosage, side effects, and therapeutic benefit of the investigational drug. Selecting the right laboratory to support both clinical trials and pre-clinical research can improve the success rate of drug development.
This whitepaper from Canopy Biosciences outlines considerations for selecting a laboratory to support oncology clinical trials and describes cases of Canopy’s support for trials investigating a biomarker assay and a therapeutic antibody drug.
Offered Free by: Bruker Scientific
See All Resources from: Bruker Scientific